Motor neuron diseases (MNDs) are fatal diseases characterized by loss of motor neurons in the brain cortex, in the bulbar region, and/or in the anterior horns of the spinal cord. While generally sporadic, inherited forms linked to mutant genes encoding altered RNA/protein products have also been described. Several different mechanisms have been found altered or dysfunctional in MNDs, like the protein quality control (PQC) system. In this review, we will discuss how the PQC system is affected in two MNDs—spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS)—and how this affects the clearance of aberrantly folded proteins, which accumulate in motor neurons, inducing dysfunctions and their death. In addition, we will discuss how the PQC system can be targeted to restore proper cell function, enhancing the survival of affected cells in MNDs.

A Crucial Role for the Protein Quality Control System in Motor Neuron Diseases / R. Cristofani, V. Crippa, M.E. Cicardi, B. Tedesco, V. Ferrari, M. Chierichetti, E. Casarotto, M. Piccolella, E. Messi, M. Galbiati, P. Rusmini, A. Poletti. - In: FRONTIERS IN AGING NEUROSCIENCE. - ISSN 1663-4365. - 12(2020 Jul 21). [10.3389/fnagi.2020.00191]

A Crucial Role for the Protein Quality Control System in Motor Neuron Diseases

R. Cristofani
Primo
;
V. Crippa
Secondo
;
M.E. Cicardi;B. Tedesco;V. Ferrari;M. Chierichetti;E. Casarotto;M. Piccolella;E. Messi;M. Galbiati;P. Rusmini
Penultimo
;
A. Poletti
Ultimo
2020

Abstract

Motor neuron diseases (MNDs) are fatal diseases characterized by loss of motor neurons in the brain cortex, in the bulbar region, and/or in the anterior horns of the spinal cord. While generally sporadic, inherited forms linked to mutant genes encoding altered RNA/protein products have also been described. Several different mechanisms have been found altered or dysfunctional in MNDs, like the protein quality control (PQC) system. In this review, we will discuss how the PQC system is affected in two MNDs—spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS)—and how this affects the clearance of aberrantly folded proteins, which accumulate in motor neurons, inducing dysfunctions and their death. In addition, we will discuss how the PQC system can be targeted to restore proper cell function, enhancing the survival of affected cells in MNDs.
motor neuron; ALS; SBMA; MND; protein quality control; CASA complex; HSPB8; BAG3; BAG1; proteasome; autophagy; misfolding; aggregation
Settore BIO/13 - Biologia Applicata
Settore BIO/09 - Fisiologia
   Alternative translation initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA
   FONDAZIONE TELETHON ETS
   GGP19128

   Motor neuron degeneration in Spinal and Bulbar Muscular Atrophy: molecular approaches to counteract mutant androgen receptor neurotoxicity
   FONDAZIONE TELETHON ETS
   GGP14039

   Selective translation of androgen receptor isoform A to prevent polyQ mediated toxicity in Kennedy’s disease
   KENNEDY'S DISEASE ASSOCIATION

   Dai modelli cellulari ai trial clinici: la malattia di Kennedy come paradigma di ricerca traslazionale
   REGIONE LOMBARDIA

   Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS)
   Co-ALS
   AGENZIA ITALIANA DEL FARMACO - AIFA
   AIFA-2016-02364678

   Stress granules and proteostasis in motor neurons: towards a mechanistic understanding of ALS (CureALS)
   CureALS
   MINISTERO DELL'ISTRUZIONE E DEL MERITO

   Membrane-less organelle pathology in ALS: identification of causes and rescuing factors (MLOMALS)
   MLOMALS
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA

   RAN translation of normal and expanded nucleotide repeat containing transcripts to neurotoxic polypetides in neurodegenerative diseases
   No RAn for old man
   FONDAZIONE CARIPLO
   2014-0686

   Targeting RAN translation in ALS (Target-RAN)
   Target-RAN
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA

   Ruolo protettivo della proteina HSPB8 nelle malattie del motoneurone
   MINISTERO DELLA SALUTE
   02347198

   Upregulation of HSPB8 as potential therapeutic approach in familial and sporadic ALS
   ALS_HSPB8
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA
   ALS_HSPB8

   Interplay between Androgenic/Anabolic Steroid and IGF-1 Signaling in Amyotrophic Lateral Sclerosis
   FONDATION THIERRY LATRAN

   The interplay between the “rna/protein quality control system” and “exosomes” as a spreading mechanism in amyotrophic lateral sclerosis (EX_ALS)
   EX_ALS
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2017F2A2C5_001

   Selective autophagic response to proteotoxicity in motorneurons and muscle of motor neuron diseases
   AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES
   16406-AFMTelethon

   Translating molecular mechanisms into ALS risk and patient's well-being
   TRANS-ALS
   FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICA
   2015-0023

   From RNA to Protein toxicity in motorneuron diseases
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2015LFPNMN_001

   From RNA to Protein toxicity in motorneuron diseases
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2015LFPNMN_006
21-lug-2020
Centro Interdipartimentale di Eccellenza per le Malattie Neurodegenerative CEND
Article (author)
File in questo prodotto:
File Dimensione Formato  
fnagi-12-00191.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 3.06 MB
Formato Adobe PDF
3.06 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/757918
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact